While we found few data sets in which a high percentage of patients had MDM2 gene amplification, in those that did (sarcoma and lung data sets27, 28), we were able to observe a trend towards or significant mutual exclusivity between Six1 overexpression and MDM2 amplification (Fig. 3h). The gene discussed is SIX1; the disease is sarcoma.